Abstract
Type 1 diabetes is characterized by immune-mediated destruction of pancreatic [beta]-cells resulting in insulin deficiency. This results in a common biochemical end-point of hyperglycaemia and risk of ketoacidosis, but the clinical presentation varies widely depending on the rate and degree of [beta]-cell failure. As a consequence, there has been increasing recognition of type 1 diabetes presenting in adulthood, and a blurring of the margins between type 1 and type 2 diabetes. These points are reflected in the most recent report on the diagnosis and classification of diabetes from the American Diabetes Association (ADA).
| Translated title of the contribution | What is type 1 diabetes? |
|---|---|
| Original language | English |
| Pages (from-to) | 1 - 5 |
| Number of pages | 5 |
| Journal | Medicine |
| Volume | 30 (1) |
| DOIs | |
| Publication status | Published - Jan 2002 |
